Mutual Fund Ownership
Ownership as on: Fri, 23 Feb, 2024

Union Value Fund Regular Growth

3/5
Equity
Amount Invested (Cr.)5.50
% of AUM2.52%

WhiteOak Capital Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)2.07
% of AUM2.43%

Union Multicap Fund Regular Growth

NA
Equity
Amount Invested (Cr.)10.74
% of AUM1.35%

Union Innovation & Opportunities Fund Regular Growth

NA
Global Fund of Funds
Amount Invested (Cr.)8.00
% of AUM1.32%

Union Small Cap Fund Regular Growth

3/5
Equity
Amount Invested (Cr.)16.49
% of AUM1.22%

FAQs about Glenmark Life Sciences share price

Glenmark Life Sciences is trading at 875.20 as on Fri Feb 23 2024 05:44:58. This is -0.13% lower as compared to its previous closing price of 876.30.

The market capitalization of Glenmark Life Sciences is 10723.39 Cr as on Fri Feb 23 2024 05:44:58.

The average broker rating on Glenmark Life Sciences is Buy. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 1 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 0 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Glenmark Life Sciences is 899.95 whereas the 52 wk low is 369.00

Glenmark Life Sciences can be analyzed on the following key metrics -

  • TTM P/E: 15.50
  • Sector P/E: 22.05
  • Dividend Yield: 4.96%
  • D/E ratio: -

Glenmark Life Sciences reported a net profit of 466.96 Cr in 2023.

Recommended For You
Images
Trending Stocks
1,945.95+37.35(1.96%)
537.35+6.10(1.15%)
3,690.25+38.45(1.05%)
1,119.30-15.95 (-1.40%)
2,979.95-38.60 (-1.28%)